Alan reaches a €5 billion valuation after fresh funding — what it means for the insurtech
French health insurance startup Alan has reached a valuation of €5 billion (about $5.83 billion) after a new €100 million ($116 million) financing round. Founded in 2016, the company has built a modern health-insurance platform and is now accelerating product development, international expansion and investments in technology and AI 🤖.
Fast facts
- Valuation: €5 billion (~$5.83B)
- New round: €100 million (~$116M), led by Index Ventures
- Team: ~740 employees
- Customers: ~1 million employees, freelancers and retirees
- ARR (2025): €785 million (~$915M), up 53% from end of 2024
Funding round and investors
The €100M round was led by existing investor Index Ventures and included new backers such as Greenoaks, Kaaf and SH, plus business angels like Shopify founder Tobi Lütke and footballer Antoine Griezmann. Belgian bank-insurer Belfius, a strategic partner that led Alan’s prior Series F, also participated.
Products, reach and growth
Alan offers a mobile-first app where users can manage reimbursements, access doctors and track health habits. Since launching, the company has scaled to roughly 740 employees and covers about one million people across corporates, freelancers and retirees.
Revenue momentum is strong: Alan reported €785M in ARR for 2025, a 53% increase from the end of 2024. That growth underpins the new valuation and the company’s plan to keep investing in product and engineering 📈.
Profitability and financial trends
Alan says it has reached operational profitability in France, its largest market, and is approaching operating break-even overall. The company recorded net losses of $61M in 2023 and $56M in 2024, but it reports having halved losses as a percentage of revenue over the past 12 months — a sign of improving unit economics.
Global expansion
Beyond France (where Alan was the first new independent insurer to be licensed since the 1980s), the company has expanded into Belgium and Spain — counting clients such as HP and Volkswagen — and has recently launched in Canada, now licensed across all provinces and beginning commercial operations 🌍.
Alan also won a public contract to insure up to 135,000 civil servants and their relatives, adding scale and diversification to its client base.
Strategy: growth over near-term profits
Alan plans to keep prioritizing international expansion and product improvements over immediate full profitability. It recently signaled a target of $1.16 billion in ARR for 2026 rather than focusing solely on short-term profit — a trade-off many growth-stage investors accept when topline expansion and market share gains look promising.
What to watch next
- Execution on international markets: Can Alan replicate its French results in Spain, Belgium and Canada?
- AI and tech investments: With its leadership tied to the AI ecosystem, expect new product features and automation to improve margins 🤖.
- Path to sustained profitability: Will ARR growth and improved unit economics be sufficient to deliver lasting profits after the expansion phase?
Alan’s new €5B valuation reflects investor confidence in its expansion strategy, product-led growth and improving profitability metrics. For the insurtech, the next 12–24 months will be critical as it scales overseas, deepens product capabilities and works to convert momentum into long-term financial sustainability 🩺🚀.